FDA Issues CRL to Regeneron for Eylea HD Extended Dosing episode artwork

EPISODE · Apr 23, 2025 · 4 MIN

FDA Issues CRL to Regeneron for Eylea HD Extended Dosing

from Eyewire News: The Podcast · host Eyewire News

The FDA responds to Regeneron’s request to extend dosing intervals for Eylea HD; Regeneron applies for a new indication for Eylea HD; and several recent executive appointments are announced in the ophthalmology industry.     Learn more about your ad choices. Visit megaphone.fm/adchoices

NOW PLAYING

FDA Issues CRL to Regeneron for Eylea HD Extended Dosing

0:00 4:44

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Eyewire News: The Podcast?

This episode is 4 minutes long.

When was this Eyewire News: The Podcast episode published?

This episode was published on April 23, 2025.

What is this episode about?

The FDA responds to Regeneron’s request to extend dosing intervals for Eylea HD; Regeneron applies for a new indication for Eylea HD; and several recent executive appointments are announced in the ophthalmology industry.     Learn more about your ad...

Can I download this Eyewire News: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!